多瑞医药 (301075)
Tibet Duo Rui Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 8000.00
- Circulating A-Shares(W): 8000.00
- Earnings Per Share(RMB): -1.0064
- Net Assets Per Share(RMB): 7.4613
- Operating Revenue(W RMB): 13699.80
- Total Profit(W RMB): -11115.16
- Net Profit Attributable to Parent(W RMB): -7972.77
- Net Profit Growth Rate(%): -366.82
- Weighted Return on Equity(%): -12.9500
- Operating Cash Flow Per Share(RMB): -0.4340
- Undistributed Profit Per Share(RMB): 0.1207
- Capital Reserve Per Share(RMB): 6.3356
2. Main Business
The main business covers:
- Research, development, production, and sales of chemical drug preparations and intermediates.
- Research, development, production, and sales of active pharmaceutical ingredients (APIs).
3. Company Basic Information
- Company Name: Tibet Duo Rui Pharmaceutical Co., Ltd.
- Listing Date: 2021-09-29
- Industry: Pharmaceutical Manufacturing
- Address: 3rd Floor, Building 1, Biomedical Park, Zone A, Economic Development Zone, Changdu City, Tibet Autonomous Region
- Website: www.duoruiyy.com
- Company Profile:The company's predecessor was Hubei Duorui Pharmaceutical Co., Ltd., which was restructured into a joint-stock company in February 2020. Based on its audited net assets as of December 31, 2019, the company converted its equity into share capital and was listed on the Shenzhen Stock Exchange ChiNext Board in September 2021. The company is primarily engaged in the research, development, production, and sales of chemical drug preparations, intermediates, and APIs.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Tibet Jiakang Times Technology Development Co., Ltd. | General Legal Person | 4667.80 | 58.35 |
| 2 | Qingdao Qingchang Enterprise Management Partnership (Limited Partnership) | General Legal Person | 589.83 | 7.37 |
| 3 | Jiaxing Qiuyang Equity Investment Partnership (Limited Partnership)-Jiaxing Qiuyu Investment Partnership (Limited Partnership) | General Legal Person | 68.68 | 0.86 |
| 4 | Shenzhen Qianhai Houbo Capital Management Co., Ltd. - Houbo Lingwang No.2 New Opportunity Private Securities Investment Fund | Private Securities Investment Fund | 31.48 | 0.39 |
| 5 | Huatai Securities Co., Ltd. | Securities Firm | 24.68 | 0.31 |
| 6 | Shenzhen Qianhai Houbo Capital Management Co., Ltd. - Houbo Shengshi Family Opportunity Private Securities Investment Fund | Private Securities Investment Fund | 23.90 | 0.30 |
5. Concept Sectors
- Infant & Child Concept
- Innovative Drugs
- Margin Trading & Securities Lending
- Loss-Making Stocks
- Consecutive Losses
- Tender Offer
- Intended Share Reduction
- Control Change
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information
